{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:42:37Z","timestamp":1720442557590},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.jviromet.2005.11.011","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T13:25:35Z","timestamp":1136467535000},"page":"205-210","source":"Crossref","is-referenced-by-count":8,"title":["Prion urine comprises a glycosaminoglycan-light chain IgG complex that can be stained by Congo red"],"prefix":"10.1016","volume":"133","author":[{"given":"Michele","family":"Halimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Dayan-Amouyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehavit","family":"Kariv-Inbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Friedman-Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tehila","family":"Mayer-Sonnenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2005.11.011_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(04)15520-7","article-title":"vCJD tissue distribution and transmission by transfusion\u2014a worst-case scenario coming true?","volume":"363","author":"Aguzzi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2005.11.011_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/JVI.67.2.643-650.1993","article-title":"Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells","volume":"67","author":"Caughey","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2005.11.011_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0889-8588(05)70417-2","article-title":"Biology and therapy of immunoglobulin deposition diseases","volume":"11","author":"Dhodapkar","year":"1997","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.jviromet.2005.11.011_bib4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"Diaz-Nido","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.jviromet.2005.11.011_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.med.55.091902.103831","article-title":"Emerging infectious threats to the blood supply","volume":"55","author":"Dodd","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jviromet.2005.11.011_bib6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1096\/fj.03-1436fje","article-title":"Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy","volume":"18","author":"Elimova","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jviromet.2005.11.011_bib7","first-page":"121","article-title":"Diagnostic and therapeutic approach of systemic amyloidosis","volume":"62","author":"Hazenberg","year":"2004","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.jviromet.2005.11.011_bib8","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1212\/01.WNL.0000161842.68793.8A","article-title":"Evaluation of urinary PrPPSc as a diagnostic test for sporadic, variant, and familial CJD","volume":"64","author":"Head","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jviromet.2005.11.011_bib9","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1074\/jbc.M411314200","article-title":"PrPPSc incorporation to cells requires endogenous glycosaminoglycan expression","volume":"280","author":"Hijazi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2005.11.011_bib10","doi-asserted-by":"crossref","first-page":"17062","DOI":"10.1074\/jbc.M500122200","article-title":"Heparan sulfate is a cellular receptor for purified infectious prions","volume":"280","author":"Horonchik","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2005.11.011_bib11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199104183241604","article-title":"Mutation of the prion protein in Libyan Jews with Creutzfeldt\u2013Jakob disease","volume":"324","author":"Hsiao","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2005.11.011_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2004.12.013","article-title":"Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases","volume":"162","author":"Kariv-Inbal","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jviromet.2005.11.011_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/JVI.74.1.411-417.2000","article-title":"Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease","volume":"74","author":"Kopacek","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2005.11.011_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/prot.20434","article-title":"Analysis of correlated domain motions in IgG light chain reveals possible mechanisms of immunological signal transduction","volume":"59","author":"Krol","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.jviromet.2005.11.011_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.1711660404","article-title":"Lysosomes as key organelles in the pathogenesis of prion encephalopathies","volume":"166","author":"Laszlo","year":"1992","journal-title":"J. Pathol."},{"key":"10.1016\/j.jviromet.2005.11.011_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2005.11.011_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.nbd.2005.05.009","article-title":"The metabolism of glycosaminoglycans is impaired in prion diseases","volume":"20","author":"Mayer-Sonnenfeld","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jviromet.2005.11.011_bib18","first-page":"622","article-title":"Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells","volume":"65","author":"McKinley","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jviromet.2005.11.011_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/abio.1993.1098","article-title":"Combined alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels","volume":"209","author":"Moller","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jviromet.2005.11.011_bib20","series-title":"The Mucopolysaccaridoses. The Metabolic and Molecular Bases of Inherited Diseases","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.jviromet.2005.11.011_bib21","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2005.11.011_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.49.3.851","article-title":"Differential allelic expression of PrP mRNA in carriers of the E200K mutation","volume":"49","author":"Rosenmann","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jviromet.2005.11.011_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2003.10.150","article-title":"Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis","volume":"312","author":"Schonberger","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jviromet.2005.11.011_bib24","doi-asserted-by":"crossref","first-page":"48817","DOI":"10.1074\/jbc.M409107200","article-title":"Immunoglobulins in urine of hamsters with scrapie","volume":"279","author":"Serban","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2005.11.011_bib25","doi-asserted-by":"crossref","first-page":"31479","DOI":"10.1074\/jbc.C100278200","article-title":"A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases","volume":"276","author":"Shaked","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2005.11.011_bib26","unstructured":"Snow, A.D., Wight, T.N., Nochlin, D., Koike, Y., Kimata, K., DeArmond, S.J., Prusiner, S.B., 1990. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann\u2013Straussler syndrome, Creutzfeldt\u2013Jakob disease and scrapie. Lab. Invest. 63 (5), 601\u2013611, *LHM: This journal is received by the Medical Library, Ein Kerem *LHC: 1963-SHELF, 1934."},{"key":"10.1016\/j.jviromet.2005.11.011_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2004.07.015","article-title":"Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt\u2013Jakob disease","volume":"50","author":"Todd","year":"2005","journal-title":"J. Infect."},{"key":"10.1016\/j.jviromet.2005.11.011_bib28","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1099\/vir.0.19153-0","article-title":"Up-regulation of cathePPSin B and cathePPSin L activities in scrapie-infected mouse Neuro2a cells","volume":"84","author":"Zhang","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2005.11.011_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2004.06.004","article-title":"Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB","volume":"82","author":"Zheng","year":"2004","journal-title":"Mol. Genet. Metab."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093405003812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093405003812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T23:22:09Z","timestamp":1586647329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093405003812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0166093405003812"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2005.11.011","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}